{"transactions":[{"id":891727,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T21:45:22.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":480000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended (the \"Plan\"): (a) on August 18, 2026, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration or forfeiture pursuant to the terms of the Plan."}],"balance_after":480000,"derivative":{"exercise_price":2.1,"expiration_date":"2036-02-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":480000},"source":{"system":"sec-edgar","filing":"0001493152-26-007612","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226007612/ownership.xml","form_type":"4"}},{"id":1279384,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:30:16.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Such options, granted on February 26, 2024, were performance-based options the vesting of which was subject to the satisfaction of milestones. On February 5, 2025, the Compensation Committee of the Board of Directors of the Issuer confirmed and determined that the milestones with respect to 12,000 options have been met and, accordingly, vested."}],"balance_after":12000,"derivative":{"exercise_price":1.25,"exercise_date":"2025-02-05","expiration_date":"2034-02-26","underlying":"Common Stock, par value $0.01 per share","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001493152-25-005407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225005407/ownership.xml","form_type":"4"}},{"id":1279383,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:30:16.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":228000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on August 5, 2025, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":228000,"derivative":{"exercise_price":2.04,"expiration_date":"2035-02-05","underlying":"Common Stock, par value $0.01 per share","underlying_shares":228000},"source":{"system":"sec-edgar","filing":"0001493152-25-005407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225005407/ownership.xml","form_type":"4"}},{"id":1620639,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:41:08.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":79567,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":79567,"derivative":{"exercise_price":1.25,"exercise_date":"2024-02-26","expiration_date":"2034-02-26","underlying":"Common Stock, par value $0.01 per share","underlying_shares":79567},"source":{"system":"sec-edgar","filing":"0001493152-24-007871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315224007871/ownership.xml","form_type":"4"}},{"id":1620638,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:41:08.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80000,"derivative":{"exercise_price":1.2684,"exercise_date":"2024-02-22","expiration_date":"2034-02-22","underlying":"Common Stock, par value $0.01 per share","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-24-007871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315224007871/ownership.xml","form_type":"4"}},{"id":1620637,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:41:08.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":80000,"derivative":{"exercise_price":1.2684,"expiration_date":"2034-02-22","underlying":"Common Stock, par value $0.01 per share","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-24-007871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315224007871/ownership.xml","form_type":"4"}},{"id":1817057,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:30:57.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on February 1, 2024, the options shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":80000,"derivative":{"exercise_price":2.43,"expiration_date":"2033-08-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-23-026630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223026630/ownership.xml","form_type":"4"}},{"id":2059375,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T11:03:25.000Z","date":"2022-12-21","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on June 21, 2023, the options shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":160000,"derivative":{"exercise_price":3.73,"expiration_date":"2032-12-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001493152-23-000874","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223000874/ownership.xml","form_type":"4"}},{"id":2423190,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-28T21:30:34.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on July 26, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":100000,"derivative":{"exercise_price":6.48,"expiration_date":"2032-01-26","underlying":"Common Stock, par value $0.01 per share","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-22-002551","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222002551/ownership.xml","form_type":"4"}},{"id":2883346,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-03T22:15:52.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on February 1, 2022, the options shall vest and shall become exercisable with respect to 50% of the common stock; and (b) on a quarterly basis thereafter over the following year, the option shall equally vest and become exercisable with respect to the remaining 50% of the common stock."}],"balance_after":190000,"derivative":{"exercise_price":8.48,"expiration_date":"2031-02-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001493152-21-002536","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315221002536/ownership.xml","form_type":"4"}},{"id":3244850,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-27T22:00:11.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":166666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":166666,"derivative":{"exercise_price":9.64,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock, par value $0.01 per share","underlying_shares":166666},"source":{"system":"sec-edgar","filing":"0001493152-20-003083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220003083/ownership.xml","form_type":"4"}},{"id":3331853,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Common Stock, par value $0.01 per share","published_at":"2019-12-26T12:36:53.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":40000,"price":10,"value":400000.0,"ownership":{"direct":false,"nature":"By MEDX Ventures Group, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in April 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include any options to purchase common stock owned by the reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Gadot is the Chief Executive Officer, Company Group Chairman and majority equity owner of MEDX Venture Group and thus may be deemed to share voting and investment power over the shares beneficially owned by this entity."}],"balance_after":136847,"source":{"system":"sec-edgar","filing":"0001493152-19-019697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219019697/ownership.xml","form_type":"4"}},{"id":4207656,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-18T20:59:15.000Z","date":"2017-09-14","kind":"grant","acquired":true,"shares":476190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest equally on an annual basis over 60 months commencing on the one year anniversary of the date of grant, and in accordance with the terms of the Issuer's Equity Incentive Plan."}],"balance_after":476190,"derivative":{"exercise_price":1.05,"expiration_date":"2027-09-14","underlying":"Common Stock, par value $0.01 per share","underlying_shares":476190},"source":{"system":"sec-edgar","filing":"0001493152-17-010718","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217010718/form4.xml","form_type":"4"}},{"id":4207655,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-18T20:59:15.000Z","date":"2017-09-14","kind":"grant","acquired":true,"shares":1336522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's Equity Incentive Plan: (a) on the six month anniversary of the date of grant, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":1336522,"derivative":{"exercise_price":1.05,"expiration_date":"2027-09-14","underlying":"Common Stock, par value $0.01 per share","underlying_shares":1336522},"source":{"system":"sec-edgar","filing":"0001493152-17-010718","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217010718/form4.xml","form_type":"4"}}]}